Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
Often referred to as the 'silent pandemic,' antimicrobial resistance (AMR) was linked to approximately five million deaths worldwide in 2019, including 1.3 million directly attributable to bacterial AMR. Contributing to this issue, approximately 47 million unnecessary antibiotic prescriptions are prescribed in the U.S. each year, according to the IQVIA Institute for Human Data Science.
WHO has declared AMR as one of the top 10 global public health threats facing humanity. In this webinar, experts share current research trends in AMR, key considerations of the current AMR environment, and solutions to positively change the trajectory of AMR.
Three key take-aways:
- Historical perspective of AMR and why there is a need for change
- Key considerations for driving awareness, research, and thought leadership in AMR
- The implications of ignoring global antimicrobial resistance
Related solutions
Leverage numerous infectious disease and vaccine experts using best-in-class data sources and the right sites.
